Clinical trials
Schizophrenia Spectrum and Other Psychotic Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 2 |
| Unknown status | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre for Addiction and Mental Health | 4 |
| Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec | 1 |
| MapLight Therapeutics | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Réseau de Santé Vitalité Health Network | 1 |
| University of Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia Spectrum and Other Psychotic Disorders | 9 |
| Psychotic Disorders | 7 |
| Schizophrenia | 6 |
| Affective Disorders, Psychotic | 2 |
| Alzheimer Disease | 1 |
| Bipolar Disorder | 1 |
| Brain Diseases | 1 |
| Central Nervous System Diseases | 1 |
| Dementia | 1 |
| Disease | 1 |
Trials
Showing 51 to 9 of 9. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.